Study Build Programmer Intern at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
InternshipExperience Level
InternshipJob Type
UnknownVisa
Pharmaceutical, Healthcare, Clinical ResearchIndustries

Requirements

  • Currently enrolled in a Master’s program for Computer Science, Data Science, Bioinformatics, Informatics, or the Life Sciences with an expected graduation date of Dec. 2026 – May 2027
  • Proficient in R, Python, or SQL programming
  • Understanding of databases and how data flows through different aggregate systems
  • Proven ability to work creatively and analytically in a problem-solving environment
  • Demonstrated teamwork and collaboration on diverse teams
  • In-depth understanding of programming, logic, data flow, and database architecture

Responsibilities

  • Develop an understanding of processes and procedures within the Data and Analytics business unit
  • Ensure system validation and reliability
  • Develop and test new ideas and/or apply innovative solutions to aid in automating existing processes
  • Ensure data collection systems and database mappings are delivered accurately and in alignment with clinical trial objectives
  • Work on a team of programmers to test and validate clinical data capture systems or develop innovative solutions to streamline existing processes
  • Gain exposure to how clinical research data is collected, validated, stored, aggregated, and transformed across enterprise level systems
  • Interact and work alongside other Clinical Data Sciences professionals, including Lilly senior management
  • Present project highlights, findings, and general accomplishments to Clinical Data Sciences professionals at the conclusion of the work period

Skills

Programming
Database Architecture
Data Flow
Electronic Data Capture
System Testing
Data Validation
Clinical Database Programming
Data Standardization
Data Normalization
Process Automation

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI